title: B-domain deleted recombinant factor VIII formulation and stability.
abstract: B-domain deleted recombinant factor VIII (BDDrFVIII) is a deletion form of human coagulation factor VIII. A lyophilized formulation of highly purified BDDrFVIII has been developed that does not require the use of blood-derived products such as human serum albumin (HSA). By avoiding the use of blood-derived products, the BDDrFVIII formulation minimizes the risk of transmitting blood-borne pathogens that may be present in plasma-derived factor VIII or in other recombinant factor VIII products that contain HSA in their formulation. Upon reconstitution with saline (4 mL), the composition of the reconstituted product (62.5 to 250 IU/mL BDDrFVIII) is 18 mg/mL sodium chloride, 3.0 mg/mL sucrose, 1.5 mg/mL L-histidine, 0.25 mg/mL calcium chloride dihydrate, and 0.1 mg/mL polysorbate 80. The optimal combination of these excipients in the lyophilized BDDrFVIII formulation provides long-term stability, as measured by a variety of analytical methods. The formulation preserves factor VIII activity of lyophilized BDDrFVIII during storage for at least 24 months at 8 degrees C, and for up to 6 months at room temperature (25 degrees C). The reconstituted product retains its factor VIII potency for at least 100 hours at 25 degrees C, which would allow it to be continuously administered via an infusion pump, assuming the product is handled under aseptic conditions.
authors.affiliation: Pharmacia AB, Stockholm, Sweden.
authors.forename: T
authors.initials: T
authors.lastname: Osterberg
authors.forename: A
authors.initials: A
authors.lastname: Fatouros
authors.forename: E
authors.initials: E
authors.lastname: Neidhardt
authors.forename: N
authors.initials: N
authors.lastname: Warne
authors.forename: M
authors.initials: M
authors.lastname: Mikaelsson
mesh_terms: D003257:Consumer Product Safety; D004355:Drug Stability; D005169:Factor VIII / Q000032:analysis / Q000302:isolation & purification / Q000592:standards*; D005612:Freeze Drying; D006801:Humans
chemical_list: C427184:recombinant factor VIII SQ; D005169:Factor VIII